Prostate Cancer Vaccines Market
Prostate Cancer Vaccines Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Prostate Cancer Vaccines Market Size and Growth
The Prostate Cancer Vaccines market is experiencing significant growth, driven by increasing prevalence of prostate cancer and advancements in immunotherapy. In 2023, the market size is estimated to reach approximately $1.5 billion, with a projected compound annual growth rate (CAGR) of 15% over the next five years, reflecting strong demand for innovative treatments. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Dendreon Corporation
◍ Curevac AG
◍ OncBioMune Pharmaceuticals
◍ Bavarian Nordic
◍ Cleveland BioLabs Inc.
◍ Advantagene
◍ Pfizer Inc.
◍ SOTIO
◍ Advaxis immunotherapies
◍ Mediolanum Farmaceutici
◍ Oncovir Inc.
◍ Vaccibody AS
◍ Vaccitech
◍ UbiVac
◍ Ultimovacs
◍ Sensei Biotherapeutics
◍ AlphaVax Inc.
The competitive landscape of the prostate cancer vaccines market features companies like Dendreon Corporation and Bavarian Nordic, focusing on immunotherapies and licensing strategies. Key players enhance market growth through innovative products, collaborations, and extensive clinical trials, driving advancements in treatment options. Sales figures vary, with Dendreon reporting $87 million (2021).
◍ Momotaro-Gene Inc.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
Request Sample Report
By Product
Tablet
Injection
Market Growth
Request Sample Report
$ X Billion USD
